NOVOZYMES A S DKK 2.0's ticker is and the CUSIP is B798FW902. A total of 8 filers reported holding NOVOZYMES A S DKK 2.0 in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $227,000 | -35.5% | 4,500 | -23.4% | 0.24% | -29.0% |
Q2 2022 | $352,000 | -46.5% | 5,873 | -38.7% | 0.33% | -34.9% |
Q1 2022 | $658,000 | -37.6% | 9,575 | -25.6% | 0.51% | -29.1% |
Q4 2021 | $1,055,000 | -18.5% | 12,870 | -32.0% | 0.72% | -24.7% |
Q3 2021 | $1,294,000 | -31.4% | 18,940 | -24.5% | 0.96% | -28.5% |
Q2 2021 | $1,886,000 | -13.2% | 25,080 | -26.3% | 1.34% | -17.4% |
Q1 2021 | $2,174,000 | +2.4% | 34,045 | -8.3% | 1.63% | +1.4% |
Q4 2020 | $2,124,000 | -9.5% | 37,110 | -0.7% | 1.60% | -17.7% |
Q3 2020 | $2,347,000 | +8.0% | 37,355 | -0.9% | 1.95% | +1.5% |
Q2 2020 | $2,173,000 | +15.2% | 37,705 | -9.0% | 1.92% | +2.3% |
Q1 2020 | $1,887,000 | -6.8% | 41,425 | -0.2% | 1.88% | +14.7% |
Q4 2019 | $2,025,000 | +15.4% | 41,499 | -0.8% | 1.64% | +10.9% |
Q3 2019 | $1,755,000 | -9.9% | 41,836 | -0.1% | 1.47% | -7.5% |
Q2 2019 | $1,947,000 | +1.4% | 41,875 | 0.0% | 1.59% | -0.6% |
Q1 2019 | $1,921,000 | +2.8% | 41,875 | -0.2% | 1.60% | -11.3% |
Q4 2018 | $1,869,000 | -19.7% | 41,965 | -1.3% | 1.81% | -8.0% |
Q3 2018 | $2,327,000 | +7.6% | 42,500 | -0.5% | 1.97% | -0.5% |
Q2 2018 | $2,163,000 | -4.8% | 42,710 | -3.1% | 1.98% | -3.9% |
Q1 2018 | $2,271,000 | -11.0% | 44,065 | -1.6% | 2.06% | -7.5% |
Q4 2017 | $2,552,000 | +9.8% | 44,790 | -1.3% | 2.22% | +8.7% |
Q3 2017 | $2,324,000 | +16.1% | 45,390 | -0.8% | 2.04% | +17.1% |
Q2 2017 | $2,001,000 | +10.2% | 45,740 | -0.1% | 1.75% | +8.0% |
Q1 2017 | $1,815,000 | +16.8% | 45,800 | +1.6% | 1.62% | +8.9% |
Q4 2016 | $1,554,000 | -19.9% | 45,080 | +2.2% | 1.49% | -22.0% |
Q3 2016 | $1,940,000 | -6.8% | 44,095 | +1.9% | 1.91% | -8.8% |
Q2 2016 | $2,081,000 | +9.0% | 43,270 | +1.9% | 2.09% | +7.2% |
Q1 2016 | $1,909,000 | -6.7% | 42,460 | -0.1% | 1.95% | -7.1% |
Q4 2015 | $2,045,000 | +18.1% | 42,485 | +7.0% | 2.10% | +14.2% |
Q3 2015 | $1,731,000 | -4.0% | 39,720 | +4.7% | 1.84% | +9.0% |
Q2 2015 | $1,803,000 | +10.3% | 37,920 | +6.2% | 1.68% | +8.4% |
Q1 2015 | $1,634,000 | +14.4% | 35,697 | +5.5% | 1.56% | +14.6% |
Q4 2014 | $1,428,000 | -1.2% | 33,830 | +1.6% | 1.36% | -4.8% |
Q3 2014 | $1,445,000 | -13.6% | 33,305 | -0.1% | 1.43% | -8.8% |
Q2 2014 | $1,673,000 | +15.1% | 33,355 | +0.9% | 1.56% | +11.7% |
Q1 2014 | $1,454,000 | +4.2% | 33,055 | 0.0% | 1.40% | -0.6% |
Q4 2013 | $1,396,000 | – | 33,055 | – | 1.41% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SOMERVILLE KURT F | 201,293 | $11,524,000 | 1.88% |
Broderick Brian C | 103,399 | $5,920,000 | 1.76% |
PUZO MICHAEL J | 87,630 | $5,016,000 | 1.64% |
Page Arthur B | 37,110 | $2,124,000 | 1.60% |
Kidder Stephen W | 82,525 | $4,725,000 | 1.57% |
Dempze Nancy E | 26,868 | $1,538,000 | 1.41% |
Hemenway Trust Co LLC | 206,884 | $11,844,000 | 1.36% |
Notis-McConarty Edward | 32,876 | $1,882,000 | 0.77% |